<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:08:04Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9659678" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9659678</identifier>
        <datestamp>2022-12-23</datestamp>
        <setSpec>npgopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Pediatr Res</journal-id>
              <journal-id journal-id-type="iso-abbrev">Pediatr Res</journal-id>
              <journal-title-group>
                <journal-title>Pediatric Research</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0031-3998</issn>
              <issn pub-type="epub">1530-0447</issn>
              <publisher>
                <publisher-name>Nature Publishing Group US</publisher-name>
                <publisher-loc>New York</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9659678</article-id>
              <article-id pub-id-type="pmcid">PMC9659678</article-id>
              <article-id pub-id-type="pmc-uid">9659678</article-id>
              <article-id pub-id-type="pmid">35568730</article-id>
              <article-id pub-id-type="pmid">35568730</article-id>
              <article-id pub-id-type="publisher-id">2104</article-id>
              <article-id pub-id-type="doi">10.1038/s41390-022-02104-w</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Population Study Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Impact of antibiotics on off-target infant gut microbiota and resistance genes in cohort studies</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lebeaux</surname>
                    <given-names>Rebecca M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Madan</surname>
                    <given-names>Juliette C.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nguyen</surname>
                    <given-names>Quang P.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Coker</surname>
                    <given-names>Modupe O.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dade</surname>
                    <given-names>Erika F.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Moroishi</surname>
                    <given-names>Yuka</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Palys</surname>
                    <given-names>Thomas J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ross</surname>
                    <given-names>Benjamin D.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pettigrew</surname>
                    <given-names>Melinda M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Morrison</surname>
                    <given-names>Hilary G.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Karagas</surname>
                    <given-names>Margaret R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Hoen</surname>
                    <given-names>Anne G.</given-names>
                  </name>
                  <address>
                    <email>anne.g.hoen@dartmouth.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.254880.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 2404</institution-id><institution>Department of Epidemiology, </institution><institution>Geisel School of Medicine at Dartmouth, </institution></institution-wrap>Hanover, NH USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.254880.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 2404</institution-id><institution>Department of Microbiology &amp; Immunology, </institution><institution>Geisel School of Medicine at Dartmouth, </institution></institution-wrap>Hanover, NH USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.414110.1</institution-id><institution>Department of Pediatrics, </institution><institution>Children’s Hospital at Dartmouth, </institution></institution-wrap>Lebanon, NH USA </aff>
                <aff id="Aff4"><label>4</label>Children’s Environmental Health &amp; Disease Prevention Research Center at Dartmouth, Hanover, NH USA </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.254880.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 2404</institution-id><institution>Department of Biomedical Data Science, </institution><institution>Geisel School of Medicine at Dartmouth, </institution></institution-wrap>Hanover, NH USA </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.430387.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8796</institution-id><institution>Department of Oral Biology, </institution><institution>Rutgers School of Dental Medicine, </institution></institution-wrap>Newark, NJ USA </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.254880.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 2404</institution-id><institution>Department of Orthopaedics, </institution><institution>Geisel School of Medicine at Dartmouth, </institution></institution-wrap>Hanover, NH USA </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Epidemiology of Microbial Diseases, </institution><institution>Yale School of Public Health, </institution></institution-wrap>New Haven, CT USA </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.144532.5</institution-id><institution-id institution-id-type="ISNI">000000012169920X</institution-id><institution>Marine Biological Laboratory, </institution></institution-wrap>Woods Hole, MA USA </aff>
                <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.254880.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 2404</institution-id><institution>Center for Molecular Epidemiology, </institution><institution>Geisel School of Medicine at Dartmouth, </institution></institution-wrap>Hanover, NH USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>14</day>
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>14</day>
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <year>2022</year>
              </pub-date>
              <volume>92</volume>
              <issue>6</issue>
              <fpage>1757</fpage>
              <lpage>1766</lpage>
              <history>
                <date date-type="received">
                  <day>29</day>
                  <month>10</month>
                  <year>2021</year>
                </date>
                <date date-type="rev-recd">
                  <day>4</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>29</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">Young children are frequently exposed to antibiotics, with the potential for collateral consequences to the gut microbiome. The impact of antibiotic exposures to off-target microbes (i.e., bacteria not targeted by treatment) and antibiotic resistance genes (ARGs) is poorly understood.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">We used metagenomic sequencing data from paired stool samples collected prior to antibiotic exposure and at 1 year from over 200 infants and a difference-in-differences approach to assess the relationship between subsequent exposures and the abundance or compositional diversity of microbes and ARGs while adjusting for covariates.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">By 1 year, the abundance of multiple species and ARGs differed by antibiotic exposure. Compared to infants never exposed to antibiotics, <italic>Bacteroides vulgatus</italic> relative abundance increased by 1.72% (95% CI: 0.19, 3.24) while <italic>Bacteroides fragilis</italic> decreased by 1.56% (95% CI: −4.32, 1.21). <italic>Bifidobacterium</italic> species also exhibited opposing trends. ARGs associated with exposure included class A beta-lactamase gene <italic>CfxA6</italic>. Among infants attending day care, <italic>Escherichia coli</italic> and ARG abundance were both positively associated with antibiotic use.</p>
                </sec>
                <sec>
                  <title>Conclusion</title>
                  <p id="Par4">Novel findings, including the importance of day care attendance, were identified through considering microbiome data at baseline and post-intervention. Thus, our study design and approach have important implications for future studies evaluating the unintended impacts of antibiotics.</p>
                </sec>
                <sec>
                  <title>Impact</title>
                  <p id="Par5">
                    <list list-type="bullet">
                      <list-item>
                        <p id="Par6">The impact of antibiotic exposure to off-target microbes and antibiotic resistance genes in the gut is poorly defined.</p>
                      </list-item>
                      <list-item>
                        <p id="Par7">We quantified these impacts in two cohort studies using a difference-in-differences approach. Novel to microbiome studies, we used pre/post-antibiotic data to emulate a randomized controlled trial.</p>
                      </list-item>
                      <list-item>
                        <p id="Par8">Compared to infants unexposed to antibiotics between baseline and 1 year, the relative abundance of multiple off-target species and antibiotic resistance genes was altered.</p>
                      </list-item>
                      <list-item>
                        <p id="Par9">Infants who attended day care and were exposed to antibiotics within the first year had a higher abundance of <italic>Escherichia coli</italic> and antibiotic resistance genes; a novel finding warranting further investigation.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
              </abstract>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© International Pediatric Research Foundation, Inc 2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1" sec-type="introduction">
              <title>Introduction</title>
              <p id="Par10">Infants and young children are exposed to more antibiotics than any other age group<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup> with an estimated 30–40% of children receiving at least one course of antibiotics within their first year of life.<sup><xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR7">7</xref></sup> Although most of these antibiotics are prescribed for acute respiratory tract infections including acute otitis media,<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup> an unintended consequence of antibiotic use is its impact on microbes other than the targeted pathogen.<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup> Understanding antibiotics’ impacts on off-target or “bystander” microbes in the infant gut, in particular, is significant for two main public health reasons.<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> First, systemic antibiotics can result in microbial dysbiosis as the developing infant gut is sensitive to perturbation.<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> Encompassing both taxonomic and metabolic changes, antibiotics and resulting dysbiosis have been associated with negative health outcomes in young children including overweight/obesity,<sup><xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR16">16</xref></sup> asthma,<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup> and celiac disease.<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> Second, antibiotic exposures can lead to antimicrobial resistance. This is a particular concern in the human gut, a known reservoir for antimicrobial resistance genes (ARGs).<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup> Indeed, multiple studies have found that antibiotic exposures lead to the proliferation of ARGs that confer resistance to the antibiotic prescribed and to other antibiotics.<sup><xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR24">24</xref></sup></p>
              <p id="Par11">Mitigation of antimicrobial resistance is a global health priority as the incidence of infections requiring second or third-line broad-spectrum antibiotics for treatment is on the rise,<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> leading to further risk of antibiotic-resistant microbial infections. Integrated strategies that consider the microbiome are increasingly becoming useful for improving the surveillance of ARGs and providing clinical recommendations to prevent antimicrobial-resistant infections.<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> Commensal bacteria can harbor ARGs and carriage prevalence of potentially pathogenic microbes can lead to antimicrobial-resistant infections. Thus, there is an urgent need to conduct epidemiologic studies and build quantitative models to understand how antibiotics affect off-target microbes, antimicrobial resistance, and unintended health outcomes.</p>
              <p id="Par12">The goal of the current study was to quantify the population-level effects of antibiotics on the abundance and diversity of off-target microbes and ARGs. Specifically, we use pre/post-antibiotic data to estimate average population-level changes to individual microbes, ARGs, and compositional diversity metrics emulating a randomized controlled trial. This difference-in-differences approach is frequently used in health services and policy research but has not been previously applied to microbiome studies.<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> The advantage of this design is that it uses baseline information (i.e., data from before the intervention) to account for intra-subject variation over time and a comparison group to assess differences among those exposed and unexposed to an intervention. This approach is equivalent to assessing the interaction effect between the exposed group and the post-intervention time point.<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> As antibiotics are often prescribed for respiratory illnesses and ear infections unnecessarily,<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup> this study offers insight that can support antibiotic stewardship practices in light of the effect of antibiotics on commensal gut microbes and ARGs.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Study cohorts</title>
                <p id="Par13">The New Hampshire Birth Cohort Study (NHBCS) is an ongoing prospective cohort study of over 2250 pregnant women and their young children from New Hampshire and Vermont. A detailed description of the cohort has been published,<sup><xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR32">32</xref></sup> but, in brief, enrollment began in 2009 to study the effects of environmental exposures on pregnant women and young children. Extensive data are available for the first year of life and include delivery and pediatric medical records, as well as interview data for 4, 8, and 12 months post-delivery. Stool samples have been collected and undergone shotgun sequencing from a subset of children throughout the first year of life but predominantly at the 6-week and 1-year timepoints. Pregnant women and their children were recruited using the NHBCS’s current Dartmouth Institutional Review Board-approved procedures by the Center for the Protection of Human Subjects.</p>
                <p id="Par14">The DIABIMMUNE Study is a cohort of infants in Finland, Estonia, and Russia focused on the hygiene or microbiota hypothesis and its potential role in the development of autoimmune diseases.<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> We used data from infants in a DIABIMMUNE sub-study that aimed to examine the role antibiotics play in microbiome development over the first 3 years of life.<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> The sub-study included 39 infants from Finland having either 0 or at least 9 antibiotic exposures within their first 3 years of life. Children in this cohort had stool samples collected throughout their early life starting at about 2 months of age. We accessed quality-controlled shotgun sequencing FASTQ files and covariate data through their publicly available website.<sup><xref ref-type="bibr" rid="CR34">34</xref></sup></p>
              </sec>
              <sec id="Sec4">
                <title>Antibiotic exposure classification</title>
                <sec id="Sec5">
                  <title>NHBCS</title>
                  <p id="Par15">We were interested in systemic antibiotic exposures between the 6-week and 1-year timepoints (to match available stool samples) with a goal of studying both exposure (yes/no) and the frequency of antibiotic courses given to all infants. A unique advantage of the NHBCS is that antibiotic prescriptions, including indication, are captured in both medical records and caregiver questionnaires administered at 4, 8, and 12 months of age.</p>
                  <p id="Par16">As outlined in Supplementary Fig. <xref rid="MOESM1" ref-type="media">S1</xref>, not all infants with stool samples available had full medical record or interview data over the first year of life. Therefore, we considered two sub-cohorts for assessing antibiotic exposure. The first cohort, the NHBCS Antibiotic Exposure Cohort, classifies antibiotic exposure from medical record and/or interview data. This cohort was used to assess differences between antibiotic exposure versus non-exposure. In this dataset, we have overall less precise knowledge of the timing of antibiotics (i.e., the exact day of antibiotic prescription) but were able to maximize the sample size. Our second cohort, the NHBCS Antibiotic Frequency Cohort, only uses antibiotic prescription data from medical records enabling us to know the number and exact timing of antibiotics prescribed. The schema, sensitivity analysis, assumptions, and sample sizes for these two sub-cohorts are available in the Supplementary Notes.</p>
                </sec>
                <sec id="Sec6">
                  <title>DIABIMMUNE Study</title>
                  <p id="Par17">To increase the external validity of this study and include subjects that were known to have a relatively high number of antibiotic exposures, infants from the DIABIMMUNE Study cohort were included. Antibiotic exposures in the DIABIMMUNE Study were collected through parental reporting of antibiotic use, duration, and reason for use as described previously.<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> Infants from the DIABIMMUNE Study were added to NHBCS sub-cohorts to make combined cohorts, referred to respectively as the Antibiotic Exposure and Antibiotic Frequency Cohorts (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S1</xref>).</p>
                </sec>
              </sec>
              <sec id="Sec7">
                <title>Stool microbiome assessment</title>
                <p id="Par18">Details on stool collection and metagenomic DNA shotgun sequencing have previously been described for the NHBCS cohort<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup> and the DIABIMMUNE Study group.<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup> For all samples, taxonomy down to the species level was assigned using MetaPhlAn3<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> and quantified using ShortBRED<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> with ARGs derived from the Comprehensive Antibiotic Resistance Database (CARD) v3.1.1.<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> In CARD, model names are sometimes annotated by microbes that they have been identified in, but this may not necessarily reflect the microbial origin. Information on the ARGs profiled is available in Supplementary Table <xref rid="MOESM2" ref-type="media">S1</xref>. Additional details are discussed in the Supplementary Notes.</p>
              </sec>
              <sec id="Sec8">
                <title>Statistical analyses</title>
                <p id="Par19">All statistical analyses were performed using R version 3.6.0,<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> with additional details on overall ARG abundance and correlation analysis in the Supplementary Notes.</p>
                <sec id="Sec9">
                  <title>Assessing individual off-target microbes and antibiotic resistance genes</title>
                  <p id="Par20">The difference-in-differences approach is frequently used in health services and policy research to estimate the effect of change due to an intervention or policy on a population when a randomized controlled trial is not possible or ethical.<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> Assumptions required for the difference-in-differences approach<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup> were assessed prior to use.</p>
                  <p id="Par21">The difference-in-difference estimate was performed using Microbiome Multivariable Associations with Linear Models (MaAsLin2).<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> Our general formula was:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{array}{l}{{{{{\rm{Abundance}}}}}}\sim \left( {{{{{{\rm{intercept}}}}}}} \right) + {{{{{\rm{sample}}}}}}\;{{{{{\rm{age}}}}}}\left( {{{{{{\rm{in}}}}}}\;{{{{{\rm{days}}}}}}} \right) + {{{{{\rm{antibiotic}}}}}}\;{{{{{\rm{exposure}}}}}} \\ + {{{{{\rm{antibiotic}}}}}}\;{{{{{\rm{exposure}}}}}} \times {{{{{\rm{sampling}}}}}}\ {{{{{\rm{interval}}}}}}\,\left( {{{{{{\rm{baseline}}}}}}\;{{{{{\rm{vs}}}}}}\;1\;{{{{{\rm{year}}}}}}} \right) \\ + \,{{{{{\rm{covariates}}}}}} + (1|{{{{{\rm{infant}}}}}})\end{array}$$\end{document}</tex-math><mml:math id="M2"><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mi mathvariant="normal">Abundance</mml:mi><mml:mo>~</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">intercept</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant="normal">sample</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">age</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">in</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">days</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant="normal">antibiotic</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">exposure</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mo>+</mml:mo><mml:mi mathvariant="normal">antibiotic</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">exposure</mml:mi><mml:mo>×</mml:mo><mml:mi mathvariant="normal">sampling</mml:mi><mml:mspace width="0.33em"/><mml:mi mathvariant="normal">interval</mml:mi><mml:mspace width="0.25em"/><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">baseline</mml:mi><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">vs</mml:mi><mml:mspace width="0.16em"/><mml:mn>1</mml:mn><mml:mspace width="0.16em"/><mml:mi mathvariant="normal">year</mml:mi></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mo>+</mml:mo><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">covariates</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>∣</mml:mo><mml:mi mathvariant="normal">infant</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="41390_2022_2104_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
                  <p id="Par22">Where abundance is the relative abundance of the microbe or ARG in each sample, sample age is the time in days of the sample collection, antibiotic exposure is a dichotomous indicator of if the infant was exposed or not exposed to an antibiotic ever, and sampling interval is a binary variable used to denote that the measurement was from baseline (~ 6 weeks or 2 months) or 1-year. Antibiotic exposure × sampling interval represents the difference-in-difference estimate or interaction between exposure and time interval. We considered intercept random effects at the infant level (1|infant).</p>
                </sec>
              </sec>
            </sec>
            <sec id="Sec10" sec-type="results">
              <title>Results</title>
              <sec id="Sec11">
                <title>Study groups</title>
                <p id="Par23">We used rigorous classification rules (Supplementary Notes) to retrospectively assess antibiotic exposure and frequency in 238 infants in the NHBCS that had shotgun sequencing data from stool samples collected at both ~6-week and ~1-year timepoints (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S1</xref>). Ultimately, we assigned 183 infants from the NHBCS as exposed or unexposed to antibiotics for a specific condition based on interview and/or medical record data (the NHBCS Antibiotic Exposure Cohort). A group of 99 infants could be classified by antibiotic frequency based on medical record data (NHBCS Antibiotic Frequency Cohort). Sensitivity analyses were used to evaluate exposure misclassification between medical record and interview data, but we found high concordance between the two methods (Supplementary Notes). In addition to infants participating in the NHBCS, we were able to classify the antibiotic exposure and frequency profiles of 33 infants with stool samples collected at approximately 2 months and 1 year from the DIABIMMUNE Study.<sup><xref ref-type="bibr" rid="CR23">23</xref></sup></p>
              </sec>
              <sec id="Sec12">
                <title>Descriptive characteristics of infants and samples</title>
                <p id="Par24">Comparisons between the DIABIMMUNE and NHBCS Antibiotic Exposure and Antibiotic Frequency sub-cohorts indicated that the proportions of infants that were female and that were born full-term were similar (Table <xref rid="Tab1" ref-type="table">1</xref>, <italic>χ</italic><sup>2</sup>
<italic>p</italic> value &gt; 0.1). Infants from the DIABIMMUNE Study were more likely than infants from at least one NHBCS sub-cohort to be vaginally delivered (<italic>χ</italic><sup>2</sup>
<italic>p</italic> value &lt; 0.1). The average baseline age and days breastfeeding of infants from the DIABIMMUNE Study was approximately 20 days greater than that of infants from the NHBCS (Kruskal–Wallis <italic>p</italic> value &lt; 0.1).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Descriptive overview of infants in the study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>New Hampshire Birth Cohort Study (NHBCS) Antibiotic Exposure Cohort (<italic>n</italic> = 183)</th><th>NHBCS Antibiotic Frequency Cohort (<italic>n</italic> = 99)</th><th>DIABIMMUNE Study (<italic>n</italic> = 33)</th></tr></thead><tbody><tr><td>Antibiotic classification derivation</td><td>Combination of medical record review and parental recall</td><td>Medical record review</td><td>Parental recall</td></tr><tr><td rowspan="2">Mean (SD) sample age in days</td><td>Baseline: 46 (15)</td><td>Baseline: 45 (16)</td><td>Baseline: 64 (15)</td></tr><tr><td>1 year: 371 (29)</td><td>1 year: 376 (29)</td><td>1 year: 366.6 (15)</td></tr><tr><td>Female</td><td>70 (38.3%)</td><td>40 (40.4%)</td><td>14 (42.4%)</td></tr><tr><td>Vaginal delivery</td><td>131 (71.6%)</td><td>67 (67.7%)</td><td>29 (87.9%)</td></tr><tr><td rowspan="2">Mean (SD) days breastfeeding by sample collection</td><td>Baseline<sup>a</sup>: 43.0 (17.7)</td><td>Baseline<sup>a</sup>: 41.8 (18.9)</td><td>Baseline: 64 (15)</td></tr><tr><td>1 year: 247 (133)</td><td>1 year: 238 (140)</td><td>1 year: 281 (99)</td></tr><tr><td rowspan="3">Attend day care by 1 year</td><td>Yes: 76 (41.5%)</td><td>Yes: 38 (38.4%)</td><td rowspan="3">N/A</td></tr><tr><td>No: 91 (49.7%)</td><td>No: 45 (45.5%)</td></tr><tr><td>Missing: 16 (8.7%)</td><td>Missing: 16 (16.2%)</td></tr><tr><td>Full-term (at least 37 weeks’ gestation)</td><td>171 (93.4%)</td><td>91 (92.0%)</td><td>31 (94.0%)</td></tr><tr><td rowspan="4">Parity</td><td>0: 89 (48.6%)</td><td>0: 44 (44.4%)</td><td rowspan="4">N/A</td></tr><tr><td>1: 62 (33.9%)</td><td>1: 41 (41.4%)</td></tr><tr><td>2+: 26 (14.2%)</td><td>2+: 13 (13.1%)</td></tr><tr><td>Missing: 6 (3.3%)</td><td>Missing: 1 (1.0%)</td></tr><tr><td rowspan="5">Maternal education level</td><td>High school or equivalent: 16 (8.7%)</td><td>High school or equivalent: 9 (9.1%)</td><td rowspan="5">N/A</td></tr><tr><td>Junior college, technical school, or some college: 26 (14.2%)</td><td>Junior college, technical school, or some college: 15 (15.2%)</td></tr><tr><td>College: 67 (36.6%)</td><td>College: 38 (38.4%)</td></tr><tr><td>Post-graduate: 71 (38.8%)</td><td>Post-graduate: 36 (36.4%)</td></tr><tr><td>Missing: 3 (1.6%)</td><td>Missing: 1 (1.0%)</td></tr><tr><td rowspan="2">Antibiotic exposure immediately following birth</td><td>6 (3.3%)</td><td rowspan="2">3 (3.0%)</td><td rowspan="2">1 (3.0%)</td></tr><tr><td>Missing: 3 (1.6%)</td></tr><tr><td rowspan="2">Number of antibiotic prescriptions between 6 weeks and 1 year</td><td rowspan="2">N/A</td><td>For otitis media: 42</td><td>For otitis media: 36</td></tr><tr><td>Not otitis media<sup>b</sup>: 5</td><td>Not otitis media: 0</td></tr><tr><td rowspan="2">Children with antibiotic exposure between 6 weeks and 1 year</td><td>For otitis media: 58 (31.7%)</td><td>For otitis media: 27 (27.3%)</td><td rowspan="2">For otitis media or any condition: 13 (39.4%)</td></tr><tr><td>For any condition<sup>c</sup>: 63 (34.4%)</td><td>For any condition: 29 (29.3%)</td></tr><tr><td rowspan="3">Number of antibiotics for otitis media given to child</td><td rowspan="3">N/A</td><td>0: 72</td><td>0: 20</td></tr><tr><td>1: 15</td><td>1: 3</td></tr><tr><td>2+: 12</td><td>2+: 10</td></tr><tr><td rowspan="3">Number of antibiotics for any reason given to child between baseline and 1-year time point</td><td rowspan="3">N/A</td><td>0: 70</td><td>0: 20</td></tr><tr><td>1: 15</td><td>1: 3</td></tr><tr><td>2+: 14</td><td>2+: 10</td></tr><tr><td rowspan="5">Number of prescriptions by antibiotic type between baseline and 1-year time point</td><td rowspan="5">N/A</td><td>Amoxicillin-type: 37</td><td>Amoxicillin-type: 20</td></tr><tr><td>Cephalosporin-type: 8</td><td>Cephalosporin-type: 7</td></tr><tr><td>Azithromycin: 2</td><td>Azithromycin: 5</td></tr><tr><td rowspan="2"/><td>Trimetoprime and sulfadiazine: 3</td></tr><tr><td>Unknown: 1</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>One infant included in both NHBCS sub-cohorts did not have available breastfeeding information at baseline.</p><p><sup>b</sup>Other reasons included: upper respiratory infection (2), pneumonia (1), bronchitis (1), and reaction to pneumococcal vaccine (1).</p><p><sup>c</sup>Other reasons included: upper respiratory infection (2), eye infection (1), pneumonia (1), and strep throat (1).</p></table-wrap-foot></table-wrap></p>
                <p id="Par25">The majority of antibiotic exposures occurred after 6 months of age and for otitis media (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). As expected based on the inclusion criteria that DIABIMMUNE Study infants would have high exposure to antibiotics over the first 3 years of life, infants in the DIABIMMUNE Study were more frequently exposed to antibiotics and, when exposed, were given more antibiotics than infants in the NHBCS. Amoxicillin-type antibiotics (e.g., amoxicillin, amoxicillin with clavulanate) were the most commonly prescribed antibiotics among all infants. The alpha diversity of samples did vary by antibiotic exposure both before and after exposure (Supplementary Notes).<fig id="Fig1"><label>Fig. 1</label><caption><title>Descriptive overview of antibiotic exposures among New Hampshire Birth Cohort and DIABIMMUNE Study infants exposed to antibiotics in the Antibiotic Frequency Cohort.</title><p>Figure only includes antibiotic exposures occurring before the 1-year stool sample collection. Samples are ordered by first antibiotic exposure. Baseline samples were collected at approximately 6 weeks for New Hampshire Birth Cohort Study participants and 2 months for DIABIMMUNE Study infants. Age of antibiotic exposure reflects the start day of antibiotic exposure. Infants with antibiotic exposures prior to the baseline microbiome collection received them immediately following birth (age 0 days).</p></caption><graphic xlink:href="41390_2022_2104_Fig1_HTML" id="d32e1274"/></fig></p>
              </sec>
              <sec id="Sec13">
                <title>Abundance of off-target microbes and antibiotic resistance genes</title>
                <p id="Par26">Since all antibiotic exposures were for non-gut-associated infections, we classified all microbes as off-target. Looking specifically at antibiotic-exposed versus unexposed infants from the NHBCS and the DIABIMMUNE Studies (Fig. <xref rid="Fig2" ref-type="fig">2a</xref> and Supplementary Table <xref rid="MOESM2" ref-type="media">S2</xref>), we found the relative abundance change for two microbes was significantly different than zero. In particular, the relative abundance of <italic>Bacteroides vulgatus</italic> across the two timepoints increased by 1.72% (95% CI: 0.19, 3.24) more than it would have if the infant was never exposed to an antibiotic, while the relative abundance of <italic>Actinomyces odontolyticus</italic> decreased by 0.008% (95% CI: 0.015, −0.001). Relative abundance changes based on antibiotic exposure went in opposing directions for <italic>Bacteroides</italic> and <italic>Bifidobacterium</italic> species. While <italic>B. vulgatus</italic> abundance increased, <italic>Bacteroides fragilis</italic> decreased by 1.42% (95% CI: −3.06, 0.23). Similarly, <italic>Bifidobacterium bifidum</italic> relative abundance increased 1.41% (95% CI: −0.44, 3.27) more than it would have if the infant was never exposed, but <italic>Bifidobacterium longum</italic> and <italic>Bifidobacterium breve</italic> decreased by 1.56% (95% CI: −4.32, 1.21) and 1.14% (95% CI: −3.55, 1.27) respectively.<fig id="Fig2"><label>Fig. 2</label><caption><title>Off-target species changes in the population due to any antibiotic exposure.</title><p><bold>a</bold> Change in the population due to antibiotic exposure in the Antibiotic Exposure Cohort (<italic>n</italic> = 216). The difference-in-difference model for the relative abundance change between exposed and unexposed infants across the two timepoints was adjusted for sample age, duration of breastfeeding, delivery mode, sex, gestational age, antibiotic use immediately following birth, study cohort, and a random effect for each subject. <bold>b</bold> Change in the population due to antibiotic exposure in NHBCS infants (<italic>n</italic> = 183). <bold>c</bold> Change in the population due to antibiotic exposure in NHBCS infants that did not attend day care by 1 year (<italic>n</italic> = 91). <bold>d</bold> Change in the population due to antibiotic exposure in NHBCS infants that did attend day care by 1 year (<italic>n</italic> = 76). <bold>b</bold> was adjusted for the same variables as <bold>a</bold> with the exception of study cohort and addition of day care attendance by 1 year. <bold>c</bold> and <bold>d</bold> models were adjusted for the same variables as <bold>b</bold> except for day care attendance by 1 year. For all plots, the 15 species with the greatest absolute change are shown. Species are ordered by the point estimate for the relative abundance change.</p></caption><graphic xlink:href="41390_2022_2104_Fig2_HTML" id="d32e1365"/></fig></p>
                <p id="Par27">As day care attendance increases an infant’s exposure to infections<sup><xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR44">44</xref></sup> and is time variant (see Supplementary Notes), we stratified NHBCS infants in the Antibiotic Exposure Cohort by day care attendance by 1 year to attempt to separate the effect of day care attendance and antibiotic exposure on off-target microbes (Fig. <xref rid="Fig2" ref-type="fig">2b–d</xref>). Some microbe associations were consistent in both day care strata (i.e., no evidence of effect modification). However, among infants who attended day care, the relative abundance of <italic>Escherichia coli</italic> and <italic>Veillonella parvula</italic> was considerably higher among infants exposed to antibiotics compared to those who were unexposed, suggesting a synergistic interaction between antibiotic exposure and day care attendance towards the abundance of certain microbes.</p>
                <p id="Par28">We also assessed the impact of antibiotic exposure on changes in ARGs over the follow-up period (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). The most significant change occurred for the Antibiotic Resistance Ontology marker (ARO): 3003097 <italic>CfxA6</italic>, which increased on average by 15.26 reads per kilobase of reference sequence per million samples reads (RPKM) (95% CI: 5.33, 25.20) more than if the infant was not exposed to antibiotics (Fig. <xref rid="Fig3" ref-type="fig">3a</xref> and Supplementary Table <xref rid="MOESM2" ref-type="media">S3</xref>). Similar results were found among infants only in the NHBCS (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>). Results stratified by day care attendance were discordant for many ARGs. Among infants that did not attend day care by 1 year (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>), <italic>CfxA6</italic> was increased among infants exposed to antibiotics, whereas a different trend in ARG abundance change was identified among infants that attended day care by 1 year. While <italic>CfxA6</italic> was no longer associated with antibiotic exposure, many other ARGs were positively associated such as <italic>mdtN</italic> (ARO: 3003548), <italic>tetM</italic> (ARO: 3000186), and <italic>mdtO</italic> (ARO: 3003549) (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Volcano plots demonstrating abundance of antibiotic resistance gene changes in the population due to any antibiotic exposure in RPKM.</title><p>Line marks <italic>p</italic> value &lt; 0.1. <bold>a</bold> Change in the population due to antibiotic exposure in the Antibiotic Exposure Cohort (<italic>n</italic> = 216). The difference-in-difference model for the relative abundance change between exposed and unexposed infants across the two timepoints was adjusted for sample age, breastfeeding duration, delivery mode, sex, gestational age, antibiotic use immediately following birth, study cohort, and a random effect for each subject. <bold>b</bold> Change in the population due to antibiotic exposure in NHBCS infants (<italic>n</italic> = 183). <bold>c</bold> Change in the population due to antibiotic exposure in NHBCS infants that did not attend day care by 1 year (<italic>n</italic> = 91). <bold>d</bold> Change in the population due to antibiotic exposure in NHBCS infants that did attend day care by 1 year (<italic>n</italic> = 76). <bold>b</bold> was adjusted for the same variables as <bold>a</bold> with the exception of study cohort and addition of day care attendance by 1 year. <bold>c</bold> and <bold>d</bold> models were adjusted for the same variables as <bold>b</bold> except for day care attendance by one year. Only antibiotic resistance genes with a baseline prevalence greater than 20% within each population are included in the plot. RPKM reads per kilobase of reference sequence per million samples reads.</p></caption><graphic xlink:href="41390_2022_2104_Fig3_HTML" id="d32e1478"/></fig></p>
                <p id="Par29">To investigate this further, we looked at overall ARG abundance in the same infants (Supplementary Table <xref rid="MOESM2" ref-type="media">S4</xref>). In the Antibiotic Exposure Cohort, there was no statistically significant mean ARG difference by antibiotic exposure between timepoints (516.16 RPKM increase in overall RPKM load among infants exposed to an antibiotic, 95% CI: −904.61, 1936.92) after adjustment for covariates. However, among infants who attended day care in the NHBCS, ARGs increased on average by 2305.54 RPKM (95% CI: −379.80, 4990.87) more in infants exposed to antibiotics than those who were not. For all analyses, while only a few ARGs changed significantly across the two timepoints, we found that the majority of the estimated mean differences for individual ARGs was greater than 0 suggesting a greater net RPKM trend increase among infants exposed to antibiotics.</p>
                <p id="Par30">To jointly evaluate associations noted in the off-target microbe and ARG analyses, we conducted a block correlation analysis using Hierarchical All-against-All association (HAllA) testing. Across the 41 species and 55 ARGs analyzed, 111 pairs and 47 clusters were identified as having a statistically significant correlation (Benjamini–Hochberg <italic>q</italic> value &lt; 0.05) among infants unexposed to antibiotics and 60 pairs and 19 clusters for exposed infants with 49 pairwise associations overlapping (Supplementary Tables <xref rid="MOESM2" ref-type="media">S5</xref> and <xref rid="MOESM2" ref-type="media">S6</xref>). Across infants both unexposed and exposed to antibiotics, <italic>E. coli</italic> was highly associated positively and negatively with many ARGs (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Results further stratified by day care attendance were similar (Supplementary Fig. <xref rid="MOESM1" ref-type="media">S2</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>Pairwise spearman correlation between species and antibiotic resistance genes by antibiotic exposure.</title><p><bold>a</bold> Infants not exposed (<italic>n</italic> = 140) and <bold>b</bold> exposed to antibiotics (<italic>n</italic> = 76). HAllA was used to determine pairwise associations that were statistically significant. Only species and antibiotic resistance genes with at least one statistically significant pairwise association were included in the plot. Dots represent statistically significant associations (Benjamini–Hochberg adjusted <italic>p</italic> value &lt; 0.05). Due to length of gene-associated model names, <italic>ileS</italic> is used as an abbreviation for <italic>Bifidobacteria</italic> intrinsic <italic>ileS</italic> conferring resistance to mupirocin and <italic>rpoB</italic> is used for <italic>Bifidobacterium rpoB</italic> conferring resistance to rifampicin.</p></caption><graphic xlink:href="41390_2022_2104_Fig4_HTML" id="d32e1545"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec14" sec-type="discussion">
              <title>Discussion</title>
              <sec id="Sec15">
                <title>Overall findings</title>
                <p id="Par31">We evaluated the off-target effects of antibiotic exposures on the infant gut microbiome and resistome among a large number of infants from the United States and Finland. Using metagenomic sequencing of pre/post-antibiotic stool samples combined with detailed covariate information from two separate cohorts, we identified and quantified the population-level impact antibiotics have on off-target microbes and ARGs within the infant gut. We found that even with a broad categorization of antibiotic exposures between approximately 6 weeks and 1 year of life, antibiotics were associated with changes to off-target microbe and ARG abundance.</p>
                <p id="Par32">In the NHBCS Antibiotic Exposure Cohort, we found that 34.4% of infants were exposed to antibiotics between approximately 6 weeks and 1 year of life with 58 out of the 63 (92.1%) antibiotic exposures prescribed for otitis media. This largely correlates with other studies from similar demographic groups that have estimated approximately 30–40% of infants are exposed to antibiotics in the first year.<sup><xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR7">7</xref></sup> Current protocols in the United States recommend antibiotics for most otitis media and lower respiratory tract infections but not for upper respiratory infections.<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup> Due to challenges in diagnosis, gastrointestinal consequences of antibiotics, and concern for the growing threat of antimicrobial resistance, many country-level antibiotic stewardship protocols encourage watchful waiting.<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> Accordingly, randomized controlled trials<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup> and population-level cross-sectional studies<sup><xref ref-type="bibr" rid="CR49">49</xref>,<xref ref-type="bibr" rid="CR50">50</xref></sup> have examined delayed, shortened, or no antibiotic therapy for uncomplicated otitis media and respiratory infections.<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup> While these studies are critical, cohort studies with combined covariate and microbiome data also yield valuable evidence in support of antibiotic stewardship practices because they reflect current treatment practices. Thus, while this study’s main goal was to provide a population-level overview of the impact of antibiotics to infant gut microbiota and the resistome, it also provides public health professionals and clinicians with quantifiable results that may be applicable to antibiotic stewardship recommendations.</p>
              </sec>
              <sec id="Sec16">
                <title>Antibiotic exposure differentially impacts commensal microbes</title>
                <p id="Par33">Commensal microbes have many roles in the infant gut microbiome that include: (1) degrading polysaccharides into useable sugars and short-chain fatty acids for other gut microbes<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup> and (2) inhibiting pathogen colonization directly through nutrient competition and bacteria-bacteria attacks<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> as well as indirectly by stimulating the development of cells necessary for innate and adaptive immunity.<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> Thus, decreased presence or abundance due to antibiotic exposure is a major concern. However, previous studies inconsistently identify particular commensal microbial abundances that have increased or decreased as a result of antibiotic exposure and often only profile results at the genus level.<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> While the majority of our results did not indicate statistically significant differences between antibiotic-exposed and unexposed infants, our results justified the need to evaluate differences below the genus level especially for <italic>Bifidobacterium</italic> and <italic>Bacteroides</italic>.</p>
                <p id="Par34"><italic>Bifidobacterium</italic> species exhibited conflicting trends in our study. The relative abundance of two species, <italic>B. longum</italic> and <italic>B. breve</italic>, consistently decreased in the antibiotic-exposed population. However, <italic>B. bifidum</italic> increased in relative abundance after antibiotic exposure. This trend suggests that antibiotic exposure may lead to long-term selection changes to favor certain species of <italic>Bifidobacterium</italic>. Limited studies have specifically assessed <italic>Bifidobacterium</italic> species,<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> but a prior study in 1.5-year-old children found that <italic>B. bifidum</italic> concentration decreased by 23% in amoxicillin exposed children compared to 54.5% in unexposed children while <italic>B. longum</italic> concentration remained consistent immediately following exposure.<sup><xref ref-type="bibr" rid="CR56">56</xref></sup> Differences identified between studies may be a result of differences in population demographics including the age of the children as well as the time period post antibiotic exposure.</p>
                <p id="Par35">We consistently identified that <italic>B. vulgatus</italic> relative abundance increased in antibiotic-exposed children but <italic>B. fragilis</italic> decreased. These results are interesting in context to the DIABIMMUNE Study that identified <italic>B. fragilis</italic> as a “single-colonization species” and <italic>B. vulgatus</italic> as a “multiple-colonization species” based on the dominance of one vs. multiple strains across time.<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> Species with multiple strains in an environment are thought to contribute to a more resilient microbiome.<sup><xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup> While we did not assess strain diversity and at least one previous study suggests these species may have a similar sensitivity to amoxicillin-based antibiotics,<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> our results underscore the need to consider differential sensitivity to antibiotics as a result of strain-level diversity, differences in biogeographical niches,<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> and variation in ARG carriage by species. Regarding ARG carriage, the CARD continually tracks the prevalence of antibiotic resistance phenotypic profiles in reference sequences for many non-pathogenic microbes. According to the CARD prevalence 3.0.9 update, there is wide variability in ARG phenotypes between commensals from the same and different genera.<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> These data, in combination with the results from this study and others assessing antimicrobial susceptibility in bacteria often considered off-target,<sup><xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup> provide further evidence that intra- and inter-species variation is important to consider.</p>
              </sec>
              <sec id="Sec17">
                <title>Describing differential patterns of antimicrobial resistance abundance</title>
                <p id="Par36">Multiple studies have assessed how antibiotic exposure after the neonatal period impact the resistome<sup><xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR63">63</xref>–<xref ref-type="bibr" rid="CR67">67</xref></sup> but have been conducted in predominantly preterm infants<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup> or contained relatively small cohorts (&lt;30 infants) of antibiotic-exposed infants.<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR63">63</xref>–<xref ref-type="bibr" rid="CR66">66</xref></sup> We found two distinct patterns in our study, but, regardless of antibiotic exposure, found that <italic>E. coli</italic> was the microbe most frequently correlated with ARGs (Fig. <xref rid="Fig4" ref-type="fig">4</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">S2</xref>).</p>
                <p id="Par37">In our Antibiotic Exposure Cohort, only ARO: 3003730 <italic>Bifidobacteria intrinsic ileS</italic> conferring resistance to mupirocin and <italic>CfxA6</italic> were statistically significantly increased among antibiotic-exposed infants (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). According to the current version of CARD resistomes (v3.0.9), ARO: 3003730, works through antibiotic target alteration and has only been found in whole-genome sequences of <italic>B. longum.</italic><sup><xref ref-type="bibr" rid="CR39">39</xref></sup> As we found that <italic>B. longum</italic> abundance decreased when this ARG increased (Fig. <xref rid="Fig2" ref-type="fig">2</xref>), this provides some evidence that this ARG may be associated with multiple species and requires follow-up studies. While we could not identify specific species hosts for <italic>CfxA6</italic>, three studies<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup> also identified <italic>CfxA6</italic> beta-lactamase gene and one study<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> identified <italic>CfxA2</italic> (another <italic>CfxA</italic> class A beta-lactamase gene<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>) as ARG markers of interest. <italic>CfxA</italic> genes work via antibiotic inactivation<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> and have been identified in a wide range of microbes from Bacillota (formally the phylum Firmicutes) and Bacteroidota (Bacteroidetes) including <italic>Bacteroides</italic>, <italic>Prevotella</italic>, and <italic>Capnocytophaga</italic> with point mutations differing between <italic>CfxA2</italic> and <italic>CfxA6.</italic><sup><xref ref-type="bibr" rid="CR67">67</xref>,<xref ref-type="bibr" rid="CR69">69</xref>–<xref ref-type="bibr" rid="CR71">71</xref></sup> The DIABIMMUNE Study found the <italic>CfxA6</italic> gene marker persisted in children long after antibiotic exposure.<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> Although some of these infants were included in our study, we independently found that the gene increased in abundance in infants in the NHBCS only (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>). The most comparable study to ours demonstrated in 662 Danish children that antibiotic exposures during the first year of life impacted the gut resistome of healthy infants.<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> In particular, they found time since antibiotic exposure and number of antibiotics influential to overall ARG abundance. In addition, they identified specific ARGs including <italic>CfxA2</italic> and <italic>APH(3’)-llla</italic> to be increased among infants exposed to a beta-lactam inhibitor compared to infants not exposed to any antibiotic. For <italic>CfxA2</italic>, they found that it was also increased among infants given another antibiotic compared to no antibiotic exposure. Although they did not have resistome measurements taken before antibiotic exposures to establish baseline ARG abundances, the results of our study aligned with these results and those presented previously in our cohort.<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> In addition, a study of healthy adults exposed to a 7-day treatment of cefprozil found specific point mutations in <italic>CfxA6</italic> were enriched in multiple participants<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> and another study identified <italic>CfxA6</italic> to be an important discriminator of gestational age.<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> Given all this data, further detailed investigations of the <italic>CfxA6</italic> gene at the sequence level are warranted.</p>
                <p id="Par38">Among infants who attended day care by 1 year, we found that multiple ARGs and the overall resistance load were comparatively much higher among infants exposed to antibiotics (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>). <italic>E. coli</italic> relative abundance increased in antibiotic-exposed infants (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>) suggesting a synergistic interaction between antibiotic exposure and day care attendance. Although we were unable to identify other studies that assessed both antibiotic exposure and day care attendance, given <italic>E. coli</italic>’s role in horizontal gene transfer<sup><xref ref-type="bibr" rid="CR72">72</xref>,<xref ref-type="bibr" rid="CR73">73</xref></sup> and previous studies in the NHBCS and others noting their association with harboring antibiotic resistance genes,<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR67">67</xref>,<xref ref-type="bibr" rid="CR74">74</xref>,<xref ref-type="bibr" rid="CR75">75</xref></sup> the corresponding changes to resistome composition aligned with changes to <italic>E. coli</italic> relative abundance.</p>
              </sec>
              <sec id="Sec18">
                <title>Strengths and limitations</title>
                <p id="Par39">While this study is one of the largest to consider the population-level impact of antibiotic exposures to the infant gut over a follow-up period, we note some important limitations. Our main limitation was the precise timing and dosage of antibiotic exposures in the NHBCS Antibiotic Exposure Cohort. To mitigate this, we utilized stool samples from the DIABIMMUNE Study as a validation cohort since it obtained both precise timing and dose of antibiotic exposures (Supplementary Notes). We also used exposure data with more precision on a smaller sample group of infants via a medical record review to assess timing and type of antibiotic exposure. Although statistical tools have used mixed-effects models to assess microbiome composition longitudinally,<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR76">76</xref></sup> the difference-in-differences approach offers a straight-forward interpretation of the effect of an intervention in a population through its strong counterfactual estimate of the effect of eliminating unnecessary antibiotic exposures on the infant gut microbiome. Moreover, the epidemiologic framework provides the flexibility for researchers to estimate the difference-in-differences using a variety of transformations, statistical packages, and tools. A major consideration, however, in formally applying the difference-in-difference approach to microbiome analyses is fully addressing inherent difference-in-difference assumptions.<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup> For instance, in this analysis, we were unable to fully account for the common trend assumption due to only having two timepoints to assess metagenomic data. However, in the process of validating our assumptions, sensitivity analysis revealed that antibiotic exposure did differentially impact some microbes and ARGs in infants depending on their day care status; a novel finding. Lastly, an important caveat to much microbiome data is inherent limitations in accurately reflecting the composition of gut microbiota and ARGs using stool samples. Thus, while we did identify the relative abundance of microbes and ARGs changing in our differential abundance analyses, we cannot rule out that the change would affect the absolute abundance, rule out unmeasured confounding, nor fully predict changes in function or the gut itself.<sup><xref ref-type="bibr" rid="CR77">77</xref></sup> Regardless, misclassification likely would be non-differential by antibiotic exposure and we still can conclude that the infant gut microbiome of antibiotic-exposed and unexposed infants is different.</p>
              </sec>
            </sec>
            <sec id="Sec19" sec-type="conclusion">
              <title>Conclusion</title>
              <p id="Par40">Our results support the notion that microbiota and the resistome should be considered when weighing the costs and benefits of antibiotic interventions. Moreover, we apply an established framework used to emulate a randomized controlled trial to the microbiome space. This enabled quantification of the magnitude of the population-level effects of antibiotic exposure in the context of other pressures impacting the developing microbiome in early life. We imagine that this novel application can be used to evaluate the potential impact of new or current antibiotic prescription practices on gut microbiota and residual impacts on ARGs.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary information</title>
              <sec id="Sec20">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41390_2022_2104_MOESM1_ESM.pdf">
                      <caption>
                        <p>Supplementary Figures and Notes</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="41390_2022_2104_MOESM2_ESM.xlsx">
                      <caption>
                        <p>Supplementary Tables</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary information</title>
              <p>The online version contains supplementary material available at 10.1038/s41390-022-02104-w.</p>
            </sec>
            <ack>
              <title>Acknowledgements</title>
              <p>We have the utmost gratitude to participants, family members, coordinators, clinicians, and researchers involved in the New Hampshire Birth Cohort. We thank Dr Scot Zens, Terran Campbell, Dr Weston Viles, and Dr Jie Zhou for their thoughtful comments and contributions.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Author contributions</title>
              <p>R.M.L., J.C.M., M.R.K., and A.G.H. designed the research. J.C.M. and M.R.K. designed the study protocols and provided oversight for cohort and the collection, processing, and analyses of samples. R.M.L. performed the data analysis. R.M.L. and A.G.H. wrote the initial manuscript draft. H.G.M. provided technical and methodological support from the Marine Biological Laboratory. Y.M., T.J.P., and E.F.D. managed the analytic samples. R.M.L., J.C.M., Q.P.N., M.O.C., B.D.R., M.M.P., M.R.K., and A.G.H. interpreted the results. All authors provided consent for publication.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>This work was funded in part by US National Institute Health under award numbers NIGMS P20GM104416, NIEHS P01ES022832 and P20ES018175, and NLM R01LM012723. Additional funds were provided by the US Environmental Protection Agency grants RD83459901 and RD83544201. R.M.L. was funded under the Host-Microbe Interactions Training Grant at Dartmouth NIAID T32AI007519.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data availability</title>
              <p>The whole metagenomic shotgun sequencing samples are available through the National Center for Biotechnology Information (NCBI) Sequence Read Archive: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra">https://www.ncbi.nlm.nih.gov/sra</ext-link> (accession number: PRJNA296814). Analytic R markdown scripts are available upon request.</p>
            </notes>
            <notes id="FPar1" notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par41">The authors declare no competing interests.</p>
            </notes>
            <notes id="FPar2">
              <title>Ethics approval and consent to participate</title>
              <p id="Par42">For participants from the New Hampshire Birth Cohort Study, pregnant women, and their children were recruited using the New Hampshire Birth Cohort Study’s current Dartmouth Institutional Review Board-approved procedures by the Center for the Protection of Human Subjects.</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>GC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Outpatient antibiotic prescribing in the United States: 2000 to 2010</article-title>
                  <source>BMC Med.</source>
                  <year>2014</year>
                  <volume>12</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1186/1741-7015-12-96</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hicks</surname>
                      <given-names>LA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011</article-title>
                  <source>Clin. Infect. Dis.</source>
                  <year>2015</year>
                  <volume>60</volume>
                  <fpage>1308</fpage>
                  <lpage>1316</lpage>
                  <pub-id pub-id-type="pmid">25747410</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stam</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Antibiotic use in infants in the first year of life in five European countries</article-title>
                  <source>Acta Paediatr. Int. J. Paediatr.</source>
                  <year>2012</year>
                  <volume>101</volume>
                  <fpage>929</fpage>
                  <lpage>934</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1651-2227.2012.02728.x</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dawson-Hahn</surname>
                      <given-names>EE</given-names>
                    </name>
                    <name>
                      <surname>Rhee</surname>
                      <given-names>KE</given-names>
                    </name>
                  </person-group>
                  <article-title>The association between antibiotics in the first year of life and child growth trajectory</article-title>
                  <source>BMC Pediatr.</source>
                  <year>2019</year>
                  <volume>19</volume>
                  <fpage>1</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1186/s12887-018-1363-9</pub-id>
                  <pub-id pub-id-type="pmid">30606158</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kinlaw</surname>
                      <given-names>AC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Trends in antibiotic use by birth season and birth year</article-title>
                  <source>Pediatrics</source>
                  <year>2017</year>
                  <volume>140</volume>
                  <fpage>e20170441</fpage>
                  <pub-id pub-id-type="doi">10.1542/peds.2017-0441</pub-id>
                  <pub-id pub-id-type="pmid">28808074</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prescription drug dispensing profiles for one million children: A population-based analysis</article-title>
                  <source>Eur. J. Clin. Pharmacol.</source>
                  <year>2013</year>
                  <volume>69</volume>
                  <fpage>581</fpage>
                  <lpage>588</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00228-012-1343-1</pub-id>
                  <pub-id pub-id-type="pmid">22791273</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Patrick</surname>
                      <given-names>DM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Decreasing antibiotic use, the gut microbiota, and asthma incidence in children: evidence from population-based and prospective cohort studies</article-title>
                  <source>Lancet Respir. Med.</source>
                  <year>2020</year>
                  <volume>8</volume>
                  <fpage>1094</fpage>
                  <lpage>1105</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2213-2600(20)30052-7</pub-id>
                  <pub-id pub-id-type="pmid">32220282</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fleming-Dutra</surname>
                      <given-names>KE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011</article-title>
                  <source>JAMA</source>
                  <year>2016</year>
                  <volume>315</volume>
                  <fpage>1864</fpage>
                  <lpage>1873</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2016.4151</pub-id>
                  <pub-id pub-id-type="pmid">27139059</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kronman</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Mangione-Smith</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Bacterial prevalence and antimicrobial prescribing trends for acute respiratory tract infections</article-title>
                  <source>Pediatrics</source>
                  <year>2014</year>
                  <volume>134</volume>
                  <fpage>e956</fpage>
                  <lpage>e965</lpage>
                  <pub-id pub-id-type="doi">10.1542/peds.2014-0605</pub-id>
                  <pub-id pub-id-type="pmid">25225144</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tedijanto</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Olesen</surname>
                      <given-names>SW</given-names>
                    </name>
                    <name>
                      <surname>Grad</surname>
                      <given-names>YH</given-names>
                    </name>
                    <name>
                      <surname>Lipsitch</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora</article-title>
                  <source>Proc. Natl Acad. Sci. USA</source>
                  <year>2018</year>
                  <volume>115</volume>
                  <fpage>E11988</fpage>
                  <lpage>E11995</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1810840115</pub-id>
                  <pub-id pub-id-type="pmid">30559213</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Morley</surname>
                      <given-names>VJ</given-names>
                    </name>
                    <name>
                      <surname>Woods</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Read</surname>
                      <given-names>AF</given-names>
                    </name>
                  </person-group>
                  <article-title>Bystander selection for antimicrobial resistance: implications for patient health</article-title>
                  <source>Trends Microbiol.</source>
                  <year>2019</year>
                  <volume>27</volume>
                  <fpage>864</fpage>
                  <lpage>877</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tim.2019.06.004</pub-id>
                  <pub-id pub-id-type="pmid">31288975</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vatanen</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The human gut microbiome in early-onset type 1 diabetes from the TEDDY study</article-title>
                  <source>Nature</source>
                  <year>2018</year>
                  <volume>562</volume>
                  <fpage>589</fpage>
                  <lpage>594</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41586-018-0620-2</pub-id>
                  <pub-id pub-id-type="pmid">30356183</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Korpela</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Childhood BMI in relation to microbiota in infancy and lifetime antibiotic use</article-title>
                  <source>Microbiome</source>
                  <year>2017</year>
                  <volume>5</volume>
                  <fpage>1</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1186/s40168-017-0245-y</pub-id>
                  <pub-id pub-id-type="pmid">28086968</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <mixed-citation publication-type="other">Uzan-Yulzari, A. et al. Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization. <italic>Nat. Commun</italic>. <bold>12</bold>, 443 (2021).</mixed-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vallianou</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Dalamaga</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Stratigou</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Karampela</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Tsigalou</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Do antibiotics cause obesity through long-term alterations in the gut microbiome? A review of current evidence</article-title>
                  <source>Curr. Obes. Rep.</source>
                  <year>2021</year>
                  <volume>10</volume>
                  <fpage>244</fpage>
                  <lpage>262</lpage>
                  <pub-id pub-id-type="doi">10.1007/s13679-021-00438-w</pub-id>
                  <pub-id pub-id-type="pmid">33945146</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wan</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Impact of exposure to antibiotics during pregnancy and infancy on childhood obesity: a systematic review and meta-analysis</article-title>
                  <source>Obesity</source>
                  <year>2020</year>
                  <volume>28</volume>
                  <fpage>793</fpage>
                  <lpage>802</lpage>
                  <pub-id pub-id-type="doi">10.1002/oby.22747</pub-id>
                  <pub-id pub-id-type="pmid">32129005</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ong</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Umetsu</surname>
                      <given-names>DT</given-names>
                    </name>
                    <name>
                      <surname>Mandl</surname>
                      <given-names>KD</given-names>
                    </name>
                  </person-group>
                  <article-title>Consequences of antibiotics and infections in infancy: Bugs, drugs, and wheezing</article-title>
                  <source>Ann. Allergy, Asthma Immunol.</source>
                  <year>2014</year>
                  <volume>112</volume>
                  <fpage>441</fpage>
                  <lpage>445.e1</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.anai.2014.01.022</pub-id>
                  <pub-id pub-id-type="pmid">24631182</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dydensborg Sander</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Association between antibiotics in the first year of life and celiac disease</article-title>
                  <source>Gastroenterology</source>
                  <year>2019</year>
                  <volume>156</volume>
                  <fpage>2217</fpage>
                  <lpage>2229</lpage>
                  <pub-id pub-id-type="doi">10.1053/j.gastro.2019.02.039</pub-id>
                  <pub-id pub-id-type="pmid">30836095</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moore</surname>
                      <given-names>AM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes</article-title>
                  <source>PLoS One</source>
                  <year>2013</year>
                  <volume>8</volume>
                  <fpage>e78822</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0078822</pub-id>
                  <pub-id pub-id-type="pmid">24236055</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salyers</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Gupta</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Human intestinal bacteria as reservoirs for antibiotic resistance genes</article-title>
                  <source>Trends Microbiol.</source>
                  <year>2004</year>
                  <volume>12</volume>
                  <fpage>412</fpage>
                  <lpage>416</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tim.2004.07.004</pub-id>
                  <pub-id pub-id-type="pmid">15337162</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gasparrini</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome</article-title>
                  <source>Nat. Microbiol.</source>
                  <year>2019</year>
                  <volume>4</volume>
                  <fpage>2285</fpage>
                  <lpage>2297</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41564-019-0550-2</pub-id>
                  <pub-id pub-id-type="pmid">31501537</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gibson</surname>
                      <given-names>MK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome</article-title>
                  <source>Nat. Microbiol.</source>
                  <year>2016</year>
                  <volume>1</volume>
                  <fpage>1</fpage>
                  <lpage>25</lpage>
                  <pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.24</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yassour</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Natural history of the infant gut microbiome and impact of antibiotic treatments on strain-level diversity and stability</article-title>
                  <source>Sci. Trans. Med</source>
                  <year>2016</year>
                  <volume>8</volume>
                  <fpage>1173</fpage>
                  <lpage>1178</lpage>
                  <pub-id pub-id-type="doi">10.1126/scitranslmed.aad0917</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Doan</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Macrolide and nonmacrolide resistance with mass azithromycin distribution</article-title>
                  <source>N. Engl. J. Med.</source>
                  <year>2020</year>
                  <volume>383</volume>
                  <fpage>1941</fpage>
                  <lpage>1950</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa2002606</pub-id>
                  <pub-id pub-id-type="pmid">33176084</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <mixed-citation publication-type="other">World Health Organization. <italic>Antimicrobial Resistance Global Report on Surveillance</italic>. 10.1007/s13312-014-0374-3 (2014).</mixed-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Relman</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Lipsitch</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Microbiome as a tool and a target in the effort to address antimicrobial resistance</article-title>
                  <source>Proc. Natl Acad. Sci. USA</source>
                  <year>2018</year>
                  <volume>115</volume>
                  <fpage>12902</fpage>
                  <lpage>12910</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1717163115</pub-id>
                  <pub-id pub-id-type="pmid">30559176</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wing</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Simon</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Bello-Gomez</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <article-title>Designing difference in difference studies: best practices for public health policy research</article-title>
                  <source>Annu. Rev. Public Health</source>
                  <year>2018</year>
                  <volume>39</volume>
                  <fpage>453</fpage>
                  <lpage>469</lpage>
                  <pub-id pub-id-type="doi">10.1146/annurev-publhealth-040617-013507</pub-id>
                  <pub-id pub-id-type="pmid">29328877</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Caniglia</surname>
                      <given-names>EC</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>EJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Difference-in-difference in the time of cholera: a gentle introduction for epidemiologists</article-title>
                  <source>Curr. Epidemiol. Rep.</source>
                  <year>2020</year>
                  <volume>7</volume>
                  <fpage>203</fpage>
                  <lpage>211</lpage>
                  <pub-id pub-id-type="doi">10.1007/s40471-020-00245-2</pub-id>
                  <pub-id pub-id-type="pmid">33791189</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <mixed-citation publication-type="other">Mas-Dalmau, G. et al. Delayed antibiotic prescription for children with respiratory infections: a randomized trial. <italic>Pediatrics</italic><bold>147</bold>, e20201323 (2021).</mixed-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gilbert-Diamond</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Rice consumption contributes to arsenic exposure in US women</article-title>
                  <source>Proc. Natl Acad. Sci. USA</source>
                  <year>2011</year>
                  <volume>108</volume>
                  <fpage>20656</fpage>
                  <lpage>20660</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1109127108</pub-id>
                  <pub-id pub-id-type="pmid">22143778</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Coker</surname>
                      <given-names>MO</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Specific class of intrapartum antibiotics relates to maturation of the infant gut microbiota: a prospective cohort study</article-title>
                  <source>BJOG Int. J. Obstet. Gynaecol.</source>
                  <year>2019</year>
                  <volume>127</volume>
                  <fpage>217</fpage>
                  <lpage>227</lpage>
                  <pub-id pub-id-type="doi">10.1111/1471-0528.15799</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Coker</surname>
                      <given-names>MO</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Infant feeding alters the longitudinal impact of birth mode on the development of the gut microbiota in the first year of life</article-title>
                  <source>Front. Microbiol.</source>
                  <year>2021</year>
                  <volume>12</volume>
                  <fpage>1</fpage>
                  <lpage>11</lpage>
                  <pub-id pub-id-type="doi">10.3389/fmicb.2021.642197</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mustonen</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Early childhood infections and the use of antibiotics and antipyretic-analgesics in Finland, Estonia and Russian Karelia</article-title>
                  <source>Acta Paediatr. Int. J. Paediatr.</source>
                  <year>2019</year>
                  <volume>108</volume>
                  <fpage>2075</fpage>
                  <lpage>2082</lpage>
                  <pub-id pub-id-type="doi">10.1111/apa.14874</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <mixed-citation publication-type="other">Diabimmune. DIABIMMUNE Antibiotics Cohort. <ext-link ext-link-type="uri" xlink:href="https://diabimmune.broadinstitute.org/diabimmune/antibiotics-cohort">https://diabimmune.broadinstitute.org/diabimmune/antibiotics-cohort</ext-link>. Accessed 15 Jan 2021.</mixed-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lebeaux</surname>
                      <given-names>RM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The infant gut resistome is associated with <italic>E. coli</italic> and early-life exposures</article-title>
                  <source>BMC Microbiol.</source>
                  <year>2021</year>
                  <volume>21</volume>
                  <fpage>1</fpage>
                  <lpage>18</lpage>
                  <pub-id pub-id-type="doi">10.1186/s12866-021-02129-x</pub-id>
                  <pub-id pub-id-type="pmid">33386072</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yassour</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Strain-level analysis of mother-to-child bacterial transmission during the first few months of life</article-title>
                  <source>Cell Host Microbe</source>
                  <year>2018</year>
                  <volume>24</volume>
                  <fpage>146</fpage>
                  <lpage>154</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.chom.2018.06.007</pub-id>
                  <pub-id pub-id-type="pmid">30001517</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Segata</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Metagenomic microbial community profiling using unique clade-specific marker genes</article-title>
                  <source>Nat. Methods</source>
                  <year>2012</year>
                  <volume>9</volume>
                  <fpage>811</fpage>
                  <lpage>814</lpage>
                  <pub-id pub-id-type="doi">10.1038/nmeth.2066</pub-id>
                  <pub-id pub-id-type="pmid">22688413</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaminski</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>High-specificity targeted functional profiling in microbial communities with ShortBRED</article-title>
                  <source>PLoS Comput. Biol.</source>
                  <year>2015</year>
                  <volume>486</volume>
                  <fpage>207</fpage>
                  <lpage>214</lpage>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alcock</surname>
                      <given-names>BP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>CARD 2020: antibiotic resistome surveillance with the Comprehensive Antibiotic Resistance Database</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2020</year>
                  <volume>48</volume>
                  <fpage>D517</fpage>
                  <lpage>D525</lpage>
                  <pub-id pub-id-type="pmid">31665441</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <mixed-citation publication-type="other">R Core Team. R: a language and environment for statistical computing (2017).</mixed-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <mixed-citation publication-type="other">Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. <italic>PLoS Comput. Biol.</italic> <bold>17</bold>, e1009442 (2021).</mixed-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaur</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Morris</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pichichero</surname>
                      <given-names>ME</given-names>
                    </name>
                  </person-group>
                  <article-title>Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era</article-title>
                  <source>Pediatrics</source>
                  <year>2017</year>
                  <volume>140</volume>
                  <fpage>1</fpage>
                  <lpage>11</lpage>
                  <pub-id pub-id-type="doi">10.1542/peds.2017-0181</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kansen</surname>
                      <given-names>HM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Risk factors for atopic diseases and recurrent respiratory tract infections in children</article-title>
                  <source>Pediatr. Pulmonol.</source>
                  <year>2020</year>
                  <volume>55</volume>
                  <fpage>3168</fpage>
                  <lpage>3179</lpage>
                  <pub-id pub-id-type="doi">10.1002/ppul.25042</pub-id>
                  <pub-id pub-id-type="pmid">32841506</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kørvel-Hanquist</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Koch</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lous</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Olsen</surname>
                      <given-names>SF</given-names>
                    </name>
                    <name>
                      <surname>Homøe</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Risk of childhood otitis media with focus on potentially modifiable factors: a Danish follow-up cohort study</article-title>
                  <source>Int. J. Pediatr. Otorhinolaryngol.</source>
                  <year>2018</year>
                  <volume>106</volume>
                  <fpage>1</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijporl.2017.12.027</pub-id>
                  <pub-id pub-id-type="pmid">29447878</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lieberthal</surname>
                      <given-names>AS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The diagnosis and management of acute otitis media</article-title>
                  <source>Pediatrics</source>
                  <year>2013</year>
                  <volume>131</volume>
                  <fpage>e964</fpage>
                  <lpage>e999</lpage>
                  <pub-id pub-id-type="doi">10.1542/peds.2012-3488</pub-id>
                  <pub-id pub-id-type="pmid">23439909</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wong</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Blumberg</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Lowe</surname>
                      <given-names>LG</given-names>
                    </name>
                  </person-group>
                  <article-title>Guidelines for the use of antibiotics in acute upper respiratory tract infections</article-title>
                  <source>Am. Fam. Physician</source>
                  <year>2006</year>
                  <volume>74</volume>
                  <fpage>956</fpage>
                  <lpage>966</lpage>
                  <pub-id pub-id-type="pmid">17002029</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>HG</given-names>
                    </name>
                    <name>
                      <surname>Dewez</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Nijman</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Yeung</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical practice guidelines for acute otitis media in children: a systematic review and appraisal of European national guidelines</article-title>
                  <source>BMJ Open</source>
                  <year>2020</year>
                  <volume>10</volume>
                  <fpage>e035343</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmjopen-2019-035343</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spiro</surname>
                      <given-names>DM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial</article-title>
                  <source>J. Am. Med. Assoc.</source>
                  <year>2006</year>
                  <volume>296</volume>
                  <fpage>1235</fpage>
                  <lpage>1241</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.296.10.1235</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tedijanto</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Grad</surname>
                      <given-names>YH</given-names>
                    </name>
                    <name>
                      <surname>Lipsitch</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Potential impact of outpatient stewardship interventions on antibiotic exposures of bacterial pathogens</article-title>
                  <source>Elife</source>
                  <year>2020</year>
                  <volume>9</volume>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.7554/eLife.52307</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chua</surname>
                      <given-names>KP</given-names>
                    </name>
                    <name>
                      <surname>Fischer</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Linder</surname>
                      <given-names>JA</given-names>
                    </name>
                  </person-group>
                  <article-title>Appropriateness of outpatient antibiotic prescribing among privately insured US patients: ICD-10-CM based cross sectional study</article-title>
                  <source>BMJ</source>
                  <year>2019</year>
                  <volume>364</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lawson</surname>
                      <given-names>MAE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem</article-title>
                  <source>ISME J.</source>
                  <year>2020</year>
                  <volume>14</volume>
                  <fpage>635</fpage>
                  <lpage>648</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41396-019-0553-2</pub-id>
                  <pub-id pub-id-type="pmid">31740752</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Covington</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pamer</surname>
                      <given-names>EG</given-names>
                    </name>
                  </person-group>
                  <article-title>The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens</article-title>
                  <source>Immunol. Rev.</source>
                  <year>2017</year>
                  <volume>279</volume>
                  <fpage>90</fpage>
                  <lpage>105</lpage>
                  <pub-id pub-id-type="doi">10.1111/imr.12563</pub-id>
                  <pub-id pub-id-type="pmid">28856737</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pamer</surname>
                      <given-names>EG</given-names>
                    </name>
                  </person-group>
                  <article-title>Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens</article-title>
                  <source>Science</source>
                  <year>2016</year>
                  <volume>352</volume>
                  <fpage>535</fpage>
                  <lpage>538</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.aad9382</pub-id>
                  <pub-id pub-id-type="pmid">27126035</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buffie</surname>
                      <given-names>CG</given-names>
                    </name>
                    <name>
                      <surname>Pamer</surname>
                      <given-names>EG</given-names>
                    </name>
                  </person-group>
                  <article-title>Microbiota-mediated colonization resistance against intestinal pathogens</article-title>
                  <source>Nat. Rev. Immunol.</source>
                  <year>2013</year>
                  <volume>13</volume>
                  <fpage>790</fpage>
                  <lpage>801</lpage>
                  <pub-id pub-id-type="doi">10.1038/nri3535</pub-id>
                  <pub-id pub-id-type="pmid">24096337</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McDonnell</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis</article-title>
                  <source>Gut Microbes</source>
                  <year>2021</year>
                  <volume>13</volume>
                  <fpage>1</fpage>
                  <lpage>18</lpage>
                  <pub-id pub-id-type="doi">10.1080/19490976.2020.1870402</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mangin</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Suau</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gotteland</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Brunser</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Pochart</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Amoxicillin treatment modifies the composition of Bifidobacterium species in infant intestinal microbiota</article-title>
                  <source>Anaerobe</source>
                  <year>2010</year>
                  <volume>16</volume>
                  <fpage>433</fpage>
                  <lpage>438</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.anaerobe.2010.06.005</pub-id>
                  <pub-id pub-id-type="pmid">20601031</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vatanen</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life</article-title>
                  <source>Nat. Microbiol.</source>
                  <year>2019</year>
                  <volume>4</volume>
                  <fpage>470</fpage>
                  <lpage>479</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41564-018-0321-5</pub-id>
                  <pub-id pub-id-type="pmid">30559407</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schwartz</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Langdon</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Dantas</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Understanding the impact of antibiotic perturbation on the human microbiome</article-title>
                  <source>Genome Med.</source>
                  <year>2020</year>
                  <volume>12</volume>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13073-020-00782-x</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <mixed-citation publication-type="other">Betriu, C., Sánchez, A., Gómez, M. &amp; Picazo, J. J. In-vitro susceptibilities of species of the. <italic>J. Antimicrob. Chemother</italic>. <bold>43</bold>, 133–136 (1999).</mixed-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Donaldson</surname>
                      <given-names>GP</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Mazmanian</surname>
                      <given-names>SK</given-names>
                    </name>
                  </person-group>
                  <article-title>Gut biogeography of the bacterial microbiota</article-title>
                  <source>Nat. Rev. Microbiol.</source>
                  <year>2015</year>
                  <volume>14</volume>
                  <fpage>20</fpage>
                  <lpage>32</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrmicro3552</pub-id>
                  <pub-id pub-id-type="pmid">26499895</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vázquez-López</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The beta-lactam resistome expressed by aerobic and anaerobic bacteria isolated from human feces of healthy donors</article-title>
                  <source>Pharmaceuticals</source>
                  <year>2021</year>
                  <volume>14</volume>
                  <fpage>1</fpage>
                  <lpage>15</lpage>
                  <pub-id pub-id-type="doi">10.3390/ph14060533</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Duranti</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence of antibiotic resistance genes among human gut-derived bifidobacteria</article-title>
                  <source>Appl. Environ. Microbiol.</source>
                  <year>2017</year>
                  <volume>83</volume>
                  <fpage>1</fpage>
                  <lpage>14</lpage>
                  <pub-id pub-id-type="doi">10.1128/AEM.02894-16</pub-id>
                </element-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sosa-Moreno</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Perinatal risk factors for fecal antibiotic resistance gene patterns in pregnant women and their infants</article-title>
                  <source>PLoS One</source>
                  <year>2020</year>
                  <volume>15</volume>
                  <fpage>1</fpage>
                  <lpage>21</lpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0234751</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bäckhed</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Dynamics and stabilization of the human gut microbiome during the first year of life</article-title>
                  <source>Cell Host Microbe</source>
                  <year>2015</year>
                  <volume>17</volume>
                  <fpage>690</fpage>
                  <lpage>703</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.chom.2015.04.004</pub-id>
                  <pub-id pub-id-type="pmid">25974306</pub-id>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moore</surname>
                      <given-names>AM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Gut resistome development in healthy twin pairs in the first year of life</article-title>
                  <source>Microbiome</source>
                  <year>2015</year>
                  <volume>3</volume>
                  <fpage>1</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="pmid">25621171</pub-id>
                </element-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rahman</surname>
                      <given-names>SF</given-names>
                    </name>
                    <name>
                      <surname>Olm</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Morowitz</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Banfield</surname>
                      <given-names>JF</given-names>
                    </name>
                  </person-group>
                  <article-title>Machine learning leveraging genomes from metagenomes identifies influential antibiotic resistance genes in the infant gut microbiome</article-title>
                  <source>mSystems</source>
                  <year>2018</year>
                  <volume>3</volume>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1128/mSystems.00123-17</pub-id>
                </element-citation>
              </ref>
              <ref id="CR67">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>X</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The infant gut resistome associates with <italic>E. coli</italic>, environmental exposures, gut microbiome maturity, and asthma-associated bacterial composition</article-title>
                  <source>Cell Host Microbe</source>
                  <year>2021</year>
                  <volume>29</volume>
                  <fpage>1</fpage>
                  <lpage>13</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.chom.2021.03.017</pub-id>
                  <pub-id pub-id-type="pmid">33444551</pub-id>
                </element-citation>
              </ref>
              <ref id="CR68">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Raymond</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The initial state of the human gut microbiome determines its reshaping by antibiotics</article-title>
                  <source>ISME J.</source>
                  <year>2016</year>
                  <volume>10</volume>
                  <fpage>707</fpage>
                  <lpage>720</lpage>
                  <pub-id pub-id-type="doi">10.1038/ismej.2015.148</pub-id>
                  <pub-id pub-id-type="pmid">26359913</pub-id>
                </element-citation>
              </ref>
              <ref id="CR69">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parker</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>CJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetic and biochemical analysis of a novel ambler class A β-lactamase responsible for cefoxitin resistance in Bacteroides species</article-title>
                  <source>Antimicrob. Agents Chemother.</source>
                  <year>1993</year>
                  <volume>37</volume>
                  <fpage>1028</fpage>
                  <lpage>1036</lpage>
                  <pub-id pub-id-type="doi">10.1128/AAC.37.5.1028</pub-id>
                  <pub-id pub-id-type="pmid">8517690</pub-id>
                </element-citation>
              </ref>
              <ref id="CR70">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tamanai-Shacoori</surname>
                      <given-names>Z</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>CfxA expression in oral clinical Capnocytophaga isolates</article-title>
                  <source>Anaerobe</source>
                  <year>2015</year>
                  <volume>35</volume>
                  <fpage>68</fpage>
                  <lpage>71</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.anaerobe.2015.07.005</pub-id>
                  <pub-id pub-id-type="pmid">26204794</pub-id>
                </element-citation>
              </ref>
              <ref id="CR71">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fernández-Canigia</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Cejas</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Gutkind</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Radice</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Detection and genetic characterization of β-lactamases in <italic>Prevotella intermedia</italic> and <italic>Prevotella nigrescens</italic> isolated from oral cavity infections and peritonsillar abscesses</article-title>
                  <source>Anaerobe</source>
                  <year>2015</year>
                  <volume>33</volume>
                  <fpage>8</fpage>
                  <lpage>13</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.anaerobe.2015.01.007</pub-id>
                  <pub-id pub-id-type="pmid">25623818</pub-id>
                </element-citation>
              </ref>
              <ref id="CR72">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shin</surname>
                      <given-names>NR</given-names>
                    </name>
                    <name>
                      <surname>Whon</surname>
                      <given-names>TW</given-names>
                    </name>
                    <name>
                      <surname>Bae</surname>
                      <given-names>JW</given-names>
                    </name>
                  </person-group>
                  <article-title>Proteobacteria: microbial signature of dysbiosis in gut microbiota</article-title>
                  <source>Trends Biotechnol.</source>
                  <year>2015</year>
                  <volume>33</volume>
                  <fpage>496</fpage>
                  <lpage>503</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tibtech.2015.06.011</pub-id>
                  <pub-id pub-id-type="pmid">26210164</pub-id>
                </element-citation>
              </ref>
              <ref id="CR73">
                <label>73.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stecher</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Maier</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Hardt</surname>
                      <given-names>WD</given-names>
                    </name>
                  </person-group>
                  <article-title>‘Blooming’ in the gut: how dysbiosis might contribute to pathogen evolution</article-title>
                  <source>Nat. Rev. Microbiol.</source>
                  <year>2013</year>
                  <volume>11</volume>
                  <fpage>277</fpage>
                  <lpage>284</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrmicro2989</pub-id>
                  <pub-id pub-id-type="pmid">23474681</pub-id>
                </element-citation>
              </ref>
              <ref id="CR74">
                <label>74.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pärnänen</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Maternal gut and breast milk microbiota affect infant gut antibiotic resistome and mobile genetic elements</article-title>
                  <source>Nat. Commun.</source>
                  <year>2018</year>
                  <volume>9</volume>
                  <fpage>1</fpage>
                  <lpage>11</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41467-018-06393-w</pub-id>
                  <pub-id pub-id-type="pmid">29317637</pub-id>
                </element-citation>
              </ref>
              <ref id="CR75">
                <label>75.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Casaburi</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria</article-title>
                  <source>Antimicrob. Resist. Infect. Control</source>
                  <year>2019</year>
                  <volume>8</volume>
                  <fpage>1</fpage>
                  <lpage>18</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13756-019-0583-6</pub-id>
                  <pub-id pub-id-type="pmid">30622702</pub-id>
                </element-citation>
              </ref>
              <ref id="CR76">
                <label>76.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>EZ</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>A two-part mixed-effects model for analyzing longitudinal microbiome compositional data</article-title>
                  <source>Bioinformatics</source>
                  <year>2016</year>
                  <volume>32</volume>
                  <fpage>2611</fpage>
                  <lpage>2617</lpage>
                  <pub-id pub-id-type="doi">10.1093/bioinformatics/btw308</pub-id>
                  <pub-id pub-id-type="pmid">27187200</pub-id>
                </element-citation>
              </ref>
              <ref id="CR77">
                <label>77.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Montassier</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner</article-title>
                  <source>Nat. Microbiol.</source>
                  <year>2021</year>
                  <volume>6</volume>
                  <fpage>1043</fpage>
                  <lpage>1054</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41564-021-00920-0</pub-id>
                  <pub-id pub-id-type="pmid">34226711</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
